Once a niche industry focused largely on food animals, the Asia Pacific animal health sector is undergoing a seismic shift. Driven by rising pet ownership, growing awareness of animal welfare, and advancements in veterinary medicine, the industry is expanding its scope to include companion animals and preventive care.
This transformation is further fueled by increasing investments in innovative technologies, such as telemedicine and diagnostic tools, which are reshaping how veterinary services are delivered. As urbanization continues and disposable incomes rise, the demand for high-quality animal healthcare solutions is expected to soar, positioning the region as a key player in the global market.
With the companion animal health market projected to surge from USD 4.51 billion in 2024 to USD 11.26 billion by 2033 at a CAGR of 10.73%, it’s clear: this is not just a regional uptick this is a revolution.
Behind this remarkable growth lies a convergence of demographic, economic, and technological tailwinds.
As urbanization and nuclear family structures reshape lifestyles in India, China, Japan, and Australia, pets have increasingly moved from the backyard to the bedroom. And as they become family, veterinary care becomes essential, and often, premium.
China Leads in Volume, But India Surges Ahead in Speed
China’s place as the undisputed leader in the Asia Pacific companion animal health market is driven by sheer numbers and momentum. With a staggering 124.1 million pets, comprising 52.6 million dogs and 71.5 million cats, China captured 19.1% of regional market revenue in 2024.
But its dominance is not only a function of population size; it is underpinned by a rapidly evolving consumer mindset. Urban Chinese pet owners are no longer satisfied with basic veterinary services, they now demand high-tech, wellness-oriented, and preventive solutions.
This includes a surging interest in smart pet technologies, gene therapies, and sophisticated diagnostic tools. Platforms like JD Health are capitalizing on this shift, driving exponential growth in sales of targeted supplements for immune health, joint care, and age-related conditions.
However, India’s trajectory may be even more compelling. While its total pet population is smaller, its growth rate and pace of innovation position it as the region’s most dynamic market.
With the fastest projected CAGR in Asia Pacific through 2033, India is leveraging both grassroots demand and top-down infrastructure investment. Initiatives like the 200-bed animal hospital opened by the Tata Group in Mumbai and Pet Scan Pro, a smartphone-based AI diagnostic tool by MimiBowBow, are examples of how public and private sectors are converging to build a tech-enabled, decentralized veterinary ecosystem. Moreover, the expansion of diagnostics and specialty clinics into Tier 2 and Tier 3 cities is reshaping access to care.
These developments reflect a broader societal shift: pets are increasingly viewed as family members, with owners willing to invest in long-term, preventive health solutions rather than reactive treatments.
Diagnostics and Super-Specialization: The New Pillars of Veterinary Care
The most transformative change underway in Asia Pacific’s animal health landscape is the migration from reactive care to proactive, precision veterinary medicine.
Clinics across the region are adopting in-house diagnostic capabilities, including digital X-rays, blood analysis, ultrasound imaging, and now even genetic screening. This push for diagnostic infrastructure is not just about clinical efficiency; it represents a fundamental reimagining of how veterinary care is delivered.
At the forefront of this trend is Veterinary Cardiologists Australia, which launched the region’s first cardiac-focused veterinary hospital in early 2025. This type of specialization, long the domain of human medicine, is becoming increasingly viable and in-demand for pets as well.
The shift is being accelerated by AI-driven tools like SK Telecom’s X Caliber, which allows veterinary clinics to analyze X-rays via the cloud, enabling near-instant diagnostics without the need for expensive in-house servers.
This has proven particularly effective in geographically dispersed or resource-limited areas, helping bridge the urban-rural care divide. The adoption of such tools is driven by a combination of veterinarian shortages, rising pet healthcare expectations, and a need to scale quality care quickly.
Market Power and Innovation: Global Giants Hold Ground, but Local Players Push Boundaries
Despite the flourishing innovation, the Asia Pacific market remains moderately to highly concentrated, with multinational corporations like Zoetis, Elanco, Boehringer Ingelheim, and Merck Animal Health holding over 60% market share.
Their advantages lie in deep R&D pipelines, broad product portfolios, and well-established veterinary networks. These global players continue to shape the market through regulatory agility and brand trust, often leading in pharmaceuticals, vaccines, and diagnostics.
However, regional and local companies are beginning to challenge the status quo. Startups in India, Thailand, and China are proving highly adaptive, leveraging digital-first platforms, AI technologies, and tailored wellness products to penetrate underserved markets.
For instance, Petdoc in Thailand and JD Health in China are democratizing access to telemedicine and digital diagnostics, especially in semi-urban and rural areas.
These disruptors are increasingly partnering with established firms or being acquired outright, highlighting a shift toward strategic M&A and hybrid go-to-market models. The challenge for smaller firms remains scaling sustainably amid high compliance costs, complex supply chains, and fierce competition from well-resourced incumbents.
Regulation: A Balancing Act Between Innovation and Oversight
Regulatory frameworks play a critical, and at times contradictory, role in shaping the companion animal health market in Asia Pacific. In mature markets such as Australia and Japan, stringent product approval protocols and labeling standards ensure quality and safety, but also slow down product launches and market entry, especially for smaller or foreign players.
These rules enhance public trust but act as barriers for rapid innovation, particularly in diagnostics and specialty pharmaceuticals.
In contrast, India and China are actively tightening their regulatory landscapes to address challenges such as antimicrobial resistance, vaccine quality, and ethical standards in animal care. While this is essential for building a credible global reputation, it also increases the regulatory burden for manufacturers.
Another complex challenge is the emergence of functional and alternative therapies, such as Ayurvedic remedies in India or TCM-based pet supplements in China.
These products often exist in a regulatory grey zone, appealing to consumer demand for natural and holistic solutions, but lacking robust clinical validation. Managing this duality, consumer preference versus scientific rigor, will be a key policy and market challenge in the coming years.
From Following to Leading: Asia Pacific’s New Role in Global Pet Care
Asia Pacific is no longer a passive participant in the global animal health narrative, it is becoming an epicenter of innovation, adoption, and growth.
What was once a lagging region in terms of veterinary sophistication is now emerging as a hub of clinical excellence and technological transformation. The shift is as much cultural as it is economic. Across China, India, Southeast Asia, and Australasia, pet ownership is now emotionally and socially significant. Pet parents are more emotionally invested, tech-literate, and proactive, demanding the same standard of care for their animals as for themselves.
Startups, diagnostics companies, wellness brands, and digital platforms are converging into a dynamic, multifaceted ecosystem.
And while global corporations continue to dominate in scale and resources, the real innovation is happening on the ground, in smart clinics, mobile apps, cloud diagnostics, and purpose-built specialty centers. This hybrid model, high-tech and high-touch, is the future of veterinary care, and Asia Pacific is building it now.
The next frontier of companion animal health won’t be defined solely by what happens in Boston, Basel, or Berlin. It will also be shaped in Bangalore, Beijing, Brisbane, and beyond.
